Nanoparticle Based Insulin Delivery System: the Next Generation Efficient Therapy for Type 1 Diabetes

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2015 Oct 27

PMID 26498972

Citations 44

Authors

Garima Sharma

Ashish Ranjan Sharma

Ju-Suk Nam

George Priya C Doss

Sang-Soo Lee

Chiranjib Chakraborty

Affiliations

Soon will be listed here.

Abstract

Diabetic cases have increased rapidly in recent years throughout the world. Currently, for type-1 diabetes mellitus (T1DM), multiple daily insulin (MDI) injections is the most popular treatment throughout the world. At this juncture, researchers are trying to develop different insulin delivery systems, especially through oral and pulmonary route using nanocarrier based delivery system. This next generation efficient therapy for T1DM may help to improve the quality of life of diabetic patients who routinely employ insulin by the subcutaneous route. In this paper, we have depicted various next generation nanocarrier based insulin delivery systems such as chitosan-insulin nanoparticles, PLGA-insulin nanoparticles, dextran-insulin nanoparticles, polyalkylcyanoacrylated-insulin nanoparticles and solid lipid-insulin nanoparticles. Modulation of these insulin nanocarriers may lead to successful oral or pulmonary insulin nanoformulations in future clinical settings. Therefore, applications and limitations of these nanoparticles in delivering insulin to the targeted site have been thoroughly discussed.

Citing Articles

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.

Electroresponsive Thiol-Yne Click-Hydrogels for Insulin Smart Delivery: Tackling Sustained Release and Leakage Control.

Munoz-Galan H, Enshaei H, Silva J, Esteves T, Ferreira F, Casanovas J ACS Appl Polym Mater. 2025; 6(14):8093-8104.

PMID: 39839886 PMC: 11745422. DOI: 10.1021/acsapm.4c00911.

Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies.

Anwarkhan S, Koilpillai J, Narayanasamy D Cureus. 2024; 16(9):e68419.

PMID: 39360065 PMC: 11446487. DOI: 10.7759/cureus.68419.

3D-Printed Phenylboronic Acid-Bearing Hydrogels for Glucose-Triggered Drug Release.

Odent J, Baleine N, Torcasio S, Gautier S, Coulembier O, Raquez J Polymers (Basel). 2024; 16(17).

PMID: 39274135 PMC: 11398034. DOI: 10.3390/polym16172502.

Advances in Nanomedicine for Precision Insulin Delivery.

Caturano A, Nilo R, Nilo D, Russo V, Santonastaso E, Galiero R Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065795 PMC: 11279564. DOI: 10.3390/ph17070945.

References

Monaco L, Geffken G, Silverstein J . Accuracy of injection site identification among children with insulin dependent diabetes mellitus: a comparison of traditional and new visual aids. Clin Pediatr (Phila). 1996; 35(4):191-7. DOI: 10.1177/000992289603500403. View

Li X, Qi J, Xie Y, Zhang X, Hu S, Xu Y . Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats. Int J Nanomedicine. 2013; 8:23-32. PMC: 3534302. DOI: 10.2147/IJN.S38507. View

Bansal T, Jaggi M, Khar R, Talegaonkar S . Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Pharm Sci. 2009; 12(1):46-78. DOI: 10.18433/j3rc77. View

Graf A, Rades T, Hook S . Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation. Eur J Pharm Sci. 2009; 37(1):53-61. DOI: 10.1016/j.ejps.2008.12.017. View

Agnihotri S, Mallikarjuna N, Aminabhavi T . Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004; 100(1):5-28. DOI: 10.1016/j.jconrel.2004.08.010. View

Kennedy F . Recent developments in insulin delivery techniques. Current status and future potential. Drugs. 1991; 42(2):213-27. DOI: 10.2165/00003495-199142020-00004. View

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Stanley S, Gagner J, Damanpour S, Yoshida M, Dordick J, Friedman J . Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science. 2012; 336(6081):604-8. PMC: 3646550. DOI: 10.1126/science.1216753. View

Russell-Jones G, Westwood S, Habberfield A . Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin. Bioconjug Chem. 1995; 6(4):459-65. DOI: 10.1021/bc00034a016. View

10.

Lochner N, Pittner F, Wirth M, Gabor F . Wheat germ agglutinin binds to the epidermal growth factor receptor of artificial Caco-2 membranes as detected by silver nanoparticle enhanced fluorescence. Pharm Res. 2003; 20(5):833-9. DOI: 10.1023/a:1023406224028. View

11.

Damge C, Michel C, Aprahamian M, Couvreur P . New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 1988; 37(2):246-51. DOI: 10.2337/diab.37.2.246. View

12.

Guo M, Rong W, Hou J, Wang D, Lu Y, Wang Y . Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Nanotechnology. 2013; 24(24):245101. DOI: 10.1088/0957-4484/24/24/245101. View

13.

Chalasani K, Russell-Jones G, Jain A, Diwan P, Jain S . Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release. 2007; 122(2):141-50. DOI: 10.1016/j.jconrel.2007.05.019. View

14.

Liu J, Zhang S, Chen P, Cheng L, Zhou W, Tang W . Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels. J Mater Sci Mater Med. 2007; 18(11):2205-10. DOI: 10.1007/s10856-007-3010-0. View

15.

Ma Z, Lim T, Lim L . Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm. 2005; 293(1-2):271-80. DOI: 10.1016/j.ijpharm.2004.12.025. View

16.

Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Matsuura Y . The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol. 1997; 139(3):785-95. PMC: 2141704. DOI: 10.1083/jcb.139.3.785. View

17.

Xia C, Wang J, Shen W . Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther. 2000; 295(2):594-600. View

18.

Prego C, Fabre M, Torres D, Alonso M . Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res. 2006; 23(3):549-56. DOI: 10.1007/s11095-006-9570-8. View

19.

Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S . Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994; 127(6 Pt 1):1617-26. PMC: 2120300. DOI: 10.1083/jcb.127.6.1617. View

20.

Uchida T, Toida Y, Sakakibara S, Miyanaga Y, Tanaka H, Nishikata M . Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers. Chem Pharm Bull (Tokyo). 2001; 49(10):1261-6. DOI: 10.1248/cpb.49.1261. View